Transplant
Ended Awarded Last action
- Contract number
- 36C24925F0089
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $335,043
Award facts
- Contract value 100% obligated
- $335,042.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrenceville, Lawrence Township, NJ 08648, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $24,089 | |
| Other Administrative Action | $0 | |
| Original award | $310,954 |
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $335,042.65 by Veterans Integrated Service Network 9 (VISN 9), a civilian agency within the Department of Veterans Affairs, for transplant-related pharmaceutical products and services. This firm fixed-price delivery order, issued on January 12, 2025, is expected to be completed by January 11, 2026, and will be performed in Lawrenceville, New Jersey. The award utilizes no set-aside designation and represents a child contract issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which carries a ceiling value of approximately $12.3 billion through April 30, 2029.
Bristol-Myers Squibb, a global biopharmaceutical company specializing in advanced oncology and immunotherapy treatments, has established itself as a critical supplier to the VA healthcare system. The company's expertise in chimeric antigen receptor (CAR) T cell therapies and specialized cancer treatments positions it to support VISN 9's clinical mission of delivering advanced medical care to eligible veterans. This delivery order continues a pattern of substantial pharmaceutical procurement by the VA, enabling continued access to innovative therapies that support transplant and related immunological procedures across the Veterans Affairs healthcare network.
Quick answers
Who was awarded contract 36C24925F0089?
36C24925F0089 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on January 12, 2025.
How much is contract 36C24925F0089 worth?
The government has obligated $335,043 on 36C24925F0089.
Is contract 36C24925F0089 an order under another contract?
Yes. 36C24925F0089 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24925F0089 competed?
The extent of competition for 36C24925F0089 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award